OUR PORTFOLIO

BIOGENES

Stage : SERIES A
Investment Amount : MYR 25,000,000.00

Biogenes Technology Sdn Bhd is a Malaysian biotechnology startup established in 2015. The company focuses on developing and commercializing molecular diagnostics and genomics technologies. Their products and solutions cater to various sectors including healthcare, animal health, agriculture, food safety, and environmental monitoring.

Biogenes is known for its innovative use of aptamers—synthetic antibodies—in its diagnostic platforms. One of their significant contributions during the COVID-19 pandemic was the development of a rapid antigen test kit called COVIDSENS™, which uses aptamer-based technology for high selectivity and sensitivity in detecting the virus.

TUULYN

Stage : PRE-SEED
Investment Amount : MYR 5,000,000.00

A business of physical retail and e-commerce trading provides an internet platform to accelerate business and enhance the consumer experience with reliable and secure transactions. TUULYN strives to become every household’s top choice for buying daily necessities, offering convenience and speed to our customers.